E

Entia Biosciences Inc
OTC:ERGO

Watchlist Manager
Entia Biosciences Inc
OTC:ERGO
Watchlist
Price: 0.0003 USD Market Closed
Market Cap: 10.1k USD

Net Margin
Entia Biosciences Inc

-525.7%
Current
-585%
Average
3.2%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-525.7%
=
Net Income
-1.4m
/
Revenue
265.5k

Net Margin Across Competitors

No Stocks Found

Entia Biosciences Inc
Glance View

Market Cap
10.1k USD
Industry
Consumer products

Entia Biosciences, Inc. operates as a biotechnology company. The company is headquartered in Sherwood, Oregon. The company went IPO on 2007-11-01. The firm also develops and markets health-related nutraceuticals and cosmeceuticals. ErgoD2 is a pharmaceutical-grade organic compound created from whole foods that contain the micro-nutrients L-ergothioneine, an amino acid that has a transporter (SLC22A4) in every human being, and vitamin D2. ErgoD2 improves iron homeostasis and mitigates iron-related disorders presenting in anemia, chronic kidney disease and select neurodegenerative diseases. The firm's ErgoD2 formulations utilize organically cultivated specialty mushrooms available from various domestic and international suppliers. These mushroom-based products are generally regarded as safe (GRAS). The firm's market and scientific research has identified mushroom species and suppliers to provide the nutritional profiles for its ErgoD2 formulations.

ERGO Intrinsic Value
Not Available
E
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-525.7%
=
Net Income
-1.4m
/
Revenue
265.5k
What is the Net Margin of Entia Biosciences Inc?

Based on Entia Biosciences Inc's most recent financial statements, the company has Net Margin of -525.7%.

Back to Top